Tag Archives: Brad Lang

Worldwide licensing agreement made on peptide developed in Silver laboratory at Case Western Reserve University

Read the Full Article at Globe Newswire.   VANCOUVER, British Columbia, July 18, 2018 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen”), in Vancouver, and Case Western Reserve University (“Case Western Reserve”) in Cleveland have entered into an exclusive worldwide licensing agreement to research, develop and … Continue reading

Posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, spinal cord injury research | Tagged , , ,

Non-invasive systemic modulation of the CSPG receptor PTPσ promotes locomotor and urinary recovery following severe contusive spinal cord injury

This poster presentation by Brad Lang was at Society of Neuroscience 2013 in San Diego and took poster honors at the Asilomar Regeneration Conference in Pacific Grove California. Topic: Spinal cord: Therapeutic strategies Authors: *B. T. LANG1, J. M. CREGG1, … Continue reading

Posted in Chronic Spinal Cord Injury Research, Neuroscience Abstracts | Tagged , , , ,